The American College of Obstetricians and Gynecologists (ACOG) has significantly strengthened its guidance on opportunistic bilateral salpingectomy (OBS) — the removal of both fallopian tubes during an otherwise planned surgery — as a powerful strategy to prevent ovarian cancer. The updated recommendation calls for routine salpingectomy during hysterectomy and encourages ob/gyns to collaborate with other surgical specialists to extend the option to patients undergoing non-gynecologic abdominal procedures like gallbladder or hernia surgery.

The science behind the move is compelling: most ovarian cancers are now believed to originate in the fallopian tubes, and removing them leaves the ovaries intact, avoiding premature menopause. But despite strong evidence, real-world implementation faces significant hurdles — including insurance coverage gaps, federal Medicaid consent rules designed for sterilization procedures, and a lack of cross-specialty training for general surgeons who could offer the procedure during routine operations.

Key Takeaways:

• OBS can reduce lifetime ovarian cancer risk by up to 78–80%, with studies confirming safety and cost-effectiveness
• Nearly 1 in 4 women who later developed high-grade serous ovarian cancer had previously undergone abdominal surgery where salpingectomy could have been offered
• An estimated 20,890 ovarian cancer cases and 12,730 deaths occur annually in the US, with no current screening method available
• Adding salpingectomy to a planned surgery adds only 5–16 minutes of operative time with minimal additional risk

Why it matters: Ovarian cancer is often diagnosed late and carries high mortality. Opportunistic salpingectomy represents a rare, actionable prevention window — but closing the gap between evidence and access will require coordinated action from insurers, policymakers, surgical societies, and training programs.